이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Aqua Bio Technology 과거 수익 실적

과거 기준 확인 0/6

Aqua Bio Technology은 연평균 19%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 연평균 10.9%의 비율로 수입이 증가했습니다. 매출은 연평균 53.2%의 비율로 증가했습니다.

주요 정보

93.2%

수익 성장률

93.4%

EPS 성장률

Chemicals 산업 성장	32.6%
매출 성장률	664.1%
자기자본 수익률	-19.6%
순이익	-10.9%
다음 실적 업데이트	06 Nov 2024

최근 과거 실적 업데이트

Recent updates

The Director of Aqua Bio Technology ASA (OB:ABT), Roger Hofseth, Just Bought A Few More Shares

Jan 20

Have Insiders Been Buying Aqua Bio Technology ASA (OB:ABT) Shares?

Dec 30

수익 및 비용 분석

Aqua Bio Technology 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

OB:ABTEC 수익, 비용 및 수입 (NOK Millions )
날짜	수익	수익	G+A 비용
30 Jun 23	14	-2	20
31 Mar 23	10	-10	18
31 Dec 22	7	-19	17
30 Sep 22	4	-20	18
30 Jun 22	2	-22	18
31 Mar 22	2	-21	18
31 Dec 21	2	-19	18
30 Sep 21	2	-18	17
30 Jun 21	1	-18	17
31 Mar 21	1	-16	16
31 Dec 20	1	-15	16
30 Sep 20	1	-13	14
30 Jun 20	1	-11	12
31 Mar 20	1	-12	12
31 Dec 19	1	-13	13
30 Sep 19	1	-26	14
30 Jun 19	1	-38	16
31 Mar 19	1	-38	16
31 Dec 18	1	-38	17
30 Sep 18	1	-30	17
30 Jun 18	2	-22	18
31 Mar 18	6	-19	20
31 Dec 17	10	-16	22
30 Sep 17	22	-6	22
30 Jun 17	33	-4	23
31 Mar 17	41	-3	28
31 Dec 16	49	1	29
30 Sep 16	47	5	27
30 Jun 16	46	13	27
31 Mar 16	42	17	20
31 Dec 15	39	17	17
30 Sep 15	34	11	17
30 Jun 15	30	10	15
31 Mar 15	26	5	16
31 Dec 14	22	1	16
30 Sep 14	21	-2	17
30 Jun 14	19	-4	17
31 Mar 14	21	0	15
31 Dec 13	23	3	14

양질의 수익: ABTEC 은(는) 현재 수익성이 없습니다.

이익 마진 증가: ABTEC 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: 지난 5년간 ABTEC 의 전년 대비 수익 성장률이 긍정적인지 판단하기에는 데이터가 부족합니다.

성장 가속화: 현재 수익성이 없기 때문에 ABTEC 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: ABTEC 은(는) 수익성이 없어 지난 해 수익 성장을 Chemicals 업계( -17.7% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: ABTEC 현재 수익성이 없기 때문에 마이너스 자본 수익률( -19.57% )을 갖습니다.

Aqua Bio Technology 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

Aqua Bio Technology ASA to Report Q4, 2024 Results on Feb 12, 2025

Aqua Bio Technology ASA to Report Fiscal Year 2020 Results on Apr 14, 2021

Recent updates

Aqua Bio Technology ASA (OB:ABTEC) completed the acquisition of 3d Innovation Nordic As from Coc Invest AS.

New major risk - Financial data availability

New major risk - Share price stability

Aqua Bio Technology ASA to Report Q4, 2024 Results on Feb 12, 2025

New minor risk - Financial data availability

Aqua Bio Technology ASA has filed a Follow-on Equity Offering in the amount of NOK 5 million.

Aqua Bio Technology ASA has completed a Follow-on Equity Offering in the amount of NOK 12.457015 million.

Aqua Bio Technology ASA (OB:ABTEC) entered into a share purchase agreement to acquire Cover Brands As from Medvind Holding As for NOK 16.5 million.

New major risk - Shareholder dilution

Aqua Bio Technology Asa Receives European Patent for Use of Chaga in Cosmetic Formulations

New minor risk - Shareholder dilution

Aqua Bio Technology ASA announced that it has received NOK 75.999999 million in funding

New major risk - Share price stability

Aqua Bio Technology ASA announced that it expects to receive NOK 76 million in funding

Aqua Bio Technology ASA (OB:ABTEC) entered into a binding agreement in principle to acquire SkinTeam Norge AS for NOK 45 million.

Aqua Bio Technology ASA Provides Earnings Guidance for the Full Year 2023

Aqua Bio Technology ASA, Annual General Meeting, Apr 28, 2023

No independent directors

Aqua Bio Technology ASA (OB:ABT) acquired Cosmed Beauty AS and Ultrabody AB from Varming Holding As.

Aqua Bio Technology ASA (OB:ABT) entered into a binding term sheet to acquire Cosmed Beauty AS and Ultrabody AB from Varming Holding As.

Aqua Bio Technology ASA (OB:ABT) entered into a binding term sheet to acquire Cosmed Beauty AS and Ultrabody AB from Varming Holding As.

No independent directors

Aqua Bio Technology ASA Announces Hydrafacial Launches Products Containing Aquabeautine XL in the UK

Chief Executive Officer recently bought kr55k worth of stock

Insider recently sold kr1.9m worth of stock

Director recently bought kr57m worth of stock

Aqua Bio Technology ASA Announces Strategic Partnership with DCP Dermoscience

Aqua Bio Technology ASA Signs Exclusive Distribution Agreement with Moana Active Skincare Limited for New Zealand and Australia

Aqua Bio Technology ASA Signs an Distribution Agreement with Galaxa Pharma Aps

Aqua Bio Technology ASA Signs Exclusive Distribution Agreement with Cosmed Beauty AS

Aqua Bio Technology ASA to Report Fiscal Year 2020 Results on Apr 14, 2021

New 90-day high: kr9.20

The Director of Aqua Bio Technology ASA (OB:ABT), Roger Hofseth, Just Bought A Few More Shares

Director recently bought kr141k worth of stock

Have Insiders Been Buying Aqua Bio Technology ASA (OB:ABT) Shares?

Aqua Bio Technology ASA Announces Completion and Approval of Safety Studies of 6 Products from the Product Series Balance & Vitality

Aqua Bio Technology Asa: Hydrafacial Has Entered into Partnership with Restorsea - Conversion Lab Launches Veritas Md Platform

Aqua Bio Technology ASA (OB:ABT) completed the acquisition of distribution of Moana Skincare from Limited Liability Company Management Company AB GROUP.

Aqua Bio Technology ASA Expects to Enter into Three-Year Agreement for the Distribution of Moana Products in New Zealand and Australia

Aqua Bio Technology ASA Announces Completion and Approval of Safety Studies by Nordic Beauty

Aqua Bio Technology ASA has completed a Follow-on Equity Offering in the amount of NOK 2.526 million.

New 90-day high - kr8.35

수익 및 비용 분석

수익 및 매출 내역

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

자기자본 수익률

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기